Viewing Study NCT00068666


Ignite Creation Date: 2025-12-24 @ 4:15 PM
Ignite Modification Date: 2026-02-22 @ 4:13 AM
Study NCT ID: NCT00068666
Status: TERMINATED
Last Update Posted: 2016-12-15
First Post: 2003-09-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Sponsor: Alliance for Clinical Trials in Oncology
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module